Log In
Print
BCIQ
Print
Print this Print this
 

myPath Melanoma test

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionAssay consisting of a 23-gene panel to differentiate malignant melanoma from benign skin lesions
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose melanoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today